Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

31 citing papers in PubMed.

1. Improved overall survival in an anti-PD-L1 treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single arm prospective phase I/II trial.Nature communications · 2025
   Trial
2. A versatile VLP-mediated CRISPR-RNP platform for precise genome editing and durable epigenome silencing in cancer.Molecular therapy. Nucleic acids · 2026
   Article
3. Comprehensive Genomic Profiling Across Diverse Tumors Using the OncoIndx® Assay: Real-World Insights From an Indian Cohort.Cureus · 2026
   Article
4. Characterization of Korean Colorectal Cancer Reveals Novel Driver Gene and Clinically Relevant Mutations.MedComm · 2026
   Article
5. Clinical Utility of Comprehensive Genomic Profiling in a Community Hospital Outside the Cancer Genomic Core Hospital Network: A Single-Center Retrospective Cohort Study.Cureus · 2026
   Article
6. Identification of HLA class II-restricted T cell receptors against shared PIK3CA mutations in patients with epithelial cancers.Cancer immunology, immunotherapy : CII · 2025
   Article
7. Deep targeted sequencing of circulating tumor DNA to inform treatment in patients with metastatic castration-resistant prostate cancer.Journal of experimental & clinical cancer research : CR · 2025
   Article
8. The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy.Signal transduction and targeted therapy · 2025
   Review
9. Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma.Nature communications · 2024
   Article
10. Deconstructing cancer with precision genome editing.Biochemical Society transactions · 2024
    Review
11. TERT Promoter Mutations Frequency Across Race, Sex, and Cancer Type.The oncologist · 2024
    Observational
12. The Study of PIK3CA Hotspot Mutations and Co-Occurring with EGFR, KRAS, and TP53 Mutations in Non-Small Cell Lung Cancer.OncoTargets and therapy · 2024
    Article
13. Frontiers in oncology · 2024
    Article
14. Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma.Research square · 2023
    Article
15. Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis.Cell death discovery · 2023
    Article
16. Case report and literature review: exploration of molecular therapeutic targets in recurrent malignant meningioma through comprehensive genetic analysis with Todai OncoPanel.Frontiers in neurology · 2023
    Article
17. Combination of Tumor Mutational Burden and Specific Gene Mutations Stratifies Outcome to Immunotherapy Across Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma.Frontiers in genetics · 2021
    Article
18. Immune Cell Infiltration Landscape of Ovarian Cancer to Identify Prognosis and Immunotherapy-Related Genes to Aid Immunotherapy.Frontiers in cell and developmental biology · 2021
    Article
19. Enhancing chemotherapy response through augmented synthetic lethality by co-targeting nucleotide excision repair and cell-cycle checkpoints.Nature communications · 2020
    Article
20. E-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterations.Human pathology · 2020
    Article

Corrections and comments

• Erratum for
  Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.2017

Authors and funding

100 authors.

Funding

Abstract

PubMed holds no abstract for this paper.